Treatment of Osteoarthritis With Celecoxib, a Cyclooxygenase-2 Inhibitor: A Randomized Controlled Trial

Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee.

Nicholas Bellamy, W. Watson Buchanan, Charles H. Goldsmith et al. · PubMed · 1988 · 7.8K citations

Medicine, Orthopaedic Surgery, Orthopedic Surgery +17

Development of criteria for the classification and reporting of osteoarthritis: Classification of osteoarthritis of the knee

Roy D. Altman, E. Asch, D. Blöch et al. · Arthritis & Rheumatism · 1986 · 6.8K citations

Medicine, Orthopaedic Surgery, Orthopedic Surgery +13

A sharper Bonferroni procedure for multiple tests of significance

Yosef Hochberg · Biometrika · 1988 · 4.7K citations

Public Health, Biostatistics, Experimental Design +13

THERAPEUTIC CRITERIA IN RHEUMATOID ARTHRITIS

Otto Steinbrocker · JAMA · 1949 · 2.9K citations

Medicine, Clinical Sciences, Internal Medicine +7

Synthesis and Biological Evaluation of the 1,5-Diarylpyrazole Class of Cyclooxygenase-2 Inhibitors:  Identification of 4-[5-(4-Methylphenyl)-3- (trifluoromethyl)-1<i>H</i>-pyrazol-1-yl]benzenesulfonamide (SC-58635, Celecoxib)

Thomas D. Penning, John J. Talley, Stephen R. Bertenshaw et al. · Journal of Medicinal Chemistry · 1997 · 2K citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17